Research ArticleOriginal Research

Patient Knowledge and Qualities of Treatment Decisions for Localized Prostate Cancer

Lisa M. Daum, Elyse N. Reamer, Julie J. Ruterbusch, Joe Liu, Margaret Holmes-Rovner and Jinping Xu
The Journal of the American Board of Family Medicine May 2017, 30 (3) 288-297; DOI: https://doi.org/10.3122/jabfm.2017.03.160298

References

  1. 1.↵
    American Cancer Society. Key statistics for prostate cancer. 2017. Available from: http://www.cancer.org/cancer/prostatecancer/detailedguide/prostate-cancer-key-statistics. Accessed March 23, 2017.
  2. 2.↵
    Centers for Disease Control and Prevention. Prostate cancer rates by race and ethnicity. Reviewed August 20, 2015; updated June 16, 2016. Available from: http://www.cdc.gov/cancer/prostate/statistics/race.htm. Accessed September 25, 2016.
  3. 3.↵
    1. Hamdy FC,
    2. Donovan JL,
    3. Lane JA,
    4. et al
    . 10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med 2016;375:1415–24.
    OpenUrl
  4. 4.↵
    1. Wilt TJ,
    2. MacDonald R,
    3. Rutks I,
    4. Shamliyan TA,
    5. Taylor BC,
    6. Kane RL
    . Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med 2008;148:435–48.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Donovan JL,
    2. Hamdy FC,
    3. Lane JA,
    4. et al
    . Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer. N Engl J Med 2016;375:1425–37.
    OpenUrl
  6. 6.↵
    1. Mohler J,
    2. Bahnson RR,
    3. Boston B,
    4. et al
    . NCCN clinical practice guidelines in oncology: prostate cancer. J Natl Compr Canc Netw 2010;8:162–200.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Thompson I,
    2. Thrasher JB,
    3. Aus G,
    4. et al
    . Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol 2007;177:2106–31.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    1. Snow SL,
    2. Panton RL,
    3. Butler LJ,
    4. et al
    . Incomplete and inconsistent information provided to men making decisions for treatment of early-stage prostate cancer. Urology 2007;69:941–5.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Xu J,
    2. Dailey RK,
    3. Eggly S,
    4. Neale AV,
    5. Schwartz KL
    . Men's perspectives on selecting their prostate cancer treatment. J Natl Med Assoc 2011;103:468–78.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Xu J,
    2. Neale AV,
    3. Dailey RK,
    4. Eggly S,
    5. Schwartz KL
    . Patient perspective on watchful waiting/active surveillance for localized prostate cancer. J Am Board Fam Med 2012;25:763–70.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Kaplan AL,
    2. Crespi CM,
    3. Saucedo JD,
    4. Connor SE,
    5. Litwin MS,
    6. Saigal CS
    . Decisional conflict in economically disadvantaged men with newly diagnosed prostate cancer: baseline results from a shared decision-making trial. Cancer 2014;120:2721–7.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Orom H,
    2. Biddle C,
    3. Underwood W 3rd.,
    4. Nelson CJ,
    5. Homish DL
    . What is a “good” treatment decision? Decisional control, knowledge, treatment decision making, and quality of life in men with clinically localized prostate cancer. Med Decis Making 2016;36:714–25.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Xu J,
    2. Janisse J,
    3. Ruterbusch J,
    4. Ager J,
    5. Schwartz KL
    . Racial differences in treatment decision-making for men with clinically localized prostate cancer: a population-based study. J Racial Ethn Health Disparities 2016;3:35–45.
    OpenUrl
  14. 14.↵
    1. Dillman D
    . Mail and telephone surveys. New York: John Wiley and Sons; 1978.
  15. 15.↵
    1. Holmes-Rovner M,
    2. Kroll J,
    3. Schmitt N,
    4. et al
    . Patient satisfaction with health care decisions: the satisfaction with decision scale. Med Decis Making 1996;16:58–64.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Steginga SK,
    2. Occhipinti S
    . The application of the heuristic-systematic processing model to treatment decision making about prostate cancer. Med Decis Making 2004;24:573–83.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Orom H,
    2. Penner LA,
    3. West BT,
    4. Downs TM,
    5. Rayford W,
    6. Underwood W
    . Personality predicts prostate cancer treatment decision-making difficulty and satisfaction. Psychooncology 2009;18:290–9.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Connolly T,
    2. Reb J
    . Regret in cancer-related decisions. Health Psychol 2005;24(4 Suppl):S29–34.
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    1. Ross L,
    2. Dark T,
    3. Orom H,
    4. et al
    . Patterns of information behavior and prostate cancer knowledge among African-American men. J Cancer Educ 2011;26:708–16.
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    1. Holmes-Rovner M,
    2. Montgomery JS,
    3. Rovner DR,
    4. et al
    . Informed decision making: assessment of the quality of physician communication about prostate cancer diagnosis and treatment. Med Decis Making 2015;35:999–1009.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Hu JC,
    2. Kwan L,
    3. Krupski TL,
    4. et al
    . Determinants of treatment regret in low-income, uninsured men with prostate cancer. Urology 2008;72:1274–9.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Jenkins R,
    2. Schover LR,
    3. Fouladi RT,
    4. et al
    . Sexuality and health-related quality of life after prostate cancer in African-American and white men treated for localized disease. J Sex Marital Ther 2004;30:79–93.
    OpenUrlPubMed
  23. 23.↵
    1. Harper FW,
    2. Nevedal A,
    3. Eggly S,
    4. Francis C,
    5. Schwartz K,
    6. Albrecht TL
    . “It's up to you and God”: understanding health behavior change in older African American survivors of colorectal cancer. Transl Behav Med 2013;3:94–103.
    OpenUrl
  24. 24.↵
    1. Fowler FJ Jr..,
    2. McNaughton Collins M,
    3. Albertsen PC,
    4. Zietman A,
    5. Elliott DB,
    6. Barry MJ
    . Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. JAMA 2000;283:3217–22.
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.↵
    1. Bill-Axelson A,
    2. Holmberg L,
    3. Garmo H,
    4. et al
    . Radical prostatectomy or watchful waiting in early prostate cancer. N Engl J Med 2014;370:932–42.
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.↵
    1. Elwyn G,
    2. Frosch D,
    3. Thomson R,
    4. et al
    . Shared decision making: a model for clinical practice. J Gen Intern Med 2012;27:1361–7.
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. Elwyn G,
    2. Lloyd A,
    3. Joseph-Williams N,
    4. et al
    . Option grids: shared decision making made easier. Patient Educ Couns 2013;90:207–12.
    OpenUrlCrossRefPubMed
  28. 28.↵
    Michigan Cancer Consortium. Making the choice: deciding what to do about prostate cancer. Available from: http://www.prostatecancerdecision.org. Accessed December 28, 2016.
  29. 29.↵
    Agency for Healthcare Research and Quality. Knowing your options: a decision aid for men with clinically localized prostate cancer. Available from: https://www.effectivehealthcare.ahrq.gov/ehc/decisionaids/prostate-cancer/. Accessed December 28, 2016.
  30. 30.↵
    1. Stacey D,
    2. Legare F,
    3. Col NF,
    4. et al
    . Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 2014;(1):CD001431.
  31. 31.↵
    1. Violette PD,
    2. Agoritsas T,
    3. Alexander P,
    4. et al
    . Decision aids for localized prostate cancer treatment choice: systematic review and meta-analysis. CA Cancer J Clin 2015;65:239–51.
    OpenUrlCrossRefPubMed
  32. 32.↵
    1. Rees C,
    2. Abed R,
    3. Sheard C
    . Development of a reliable and valid questionnaire to test the prostate cancer knowledge of men with the disease. Patient Educ Couns 2003;51:285–92.
    OpenUrlPubMed
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Keywords